The corona virus has affected millions of people and more than thirty thousand people have died worldwide since its outbreak from Wuhan city of China in December last year. This has forced people to live in seclusion (quarantine), keep distance from all, and force countries to close their populations. This will lead to the biggest destruction in the global economy so far, leading to a major decline in GDP worldwide. In India, we are witnessing a three-week lockdown for 18% of the world’s population. This is having a tremendous impact on ensuring the flow of everyday goods and goods to the citizens as well as the supply of essential commodities to counter the epidemic.
In this environment of uncertainty, the biggest risk facing all countries is the potential breakdown of their health systems, resources and supply chains. Medical supplies, test kits, respirators, masks, tubes, robsch thermometers, hazmet suits and health workers in Kovid-19 countries have grown rapidly in demand at a time when traditional global supply chains are closing.
After the MERS (MARS) outbreak in 2015, which severely weakened its economy, South Korea analyzed what went wrong. There were not enough test kits, due to which people suffering from MERS (MARS) were running from one hospital to another to detect and confirm the disease. In addition, about 83% of the transmission was due to only five super-spreaders — 44%, or about 81 out of 186 people affected by MERS, due to the disease in 16 hospitals. What would have happened if a detailed test had been done, the links had been drawn up and those five people had been separated to prevent it from spreading?
One of the reasons for frequent testing is the large-scale availability of test kits and ancillary medical supplies. Most virus detection kits are available only in large cities. The epidemic does not recognize geographic boundaries, race, ethnicity, and economic status. By supporting a single health care system, no region will be so tolerant of pandemics in the future, some of which may be even more dangerous than Kovid-19. The world will have to think differently; Have to think better.
The truth is that an excellent healthcare system will still fall short when dealing with an epidemic. The number of intensive care rooms and associated survival devices will be much higher than normal in an epidemic. This underscores the need for a huge supply chain that will grow at short notice.
In most parts, the traditional health care supply chain consists of highly specialized and relatively small factory units. Achieving height is not a decision; Rather it is a skill. Scaling requires sophisticated processes of high-volume planning, credit, global infrastructure, social capital, and pricing. This is why even in China, the traditional health care supply chain was not sufficient to meet the demand for survival tools such as masks. BYD (EV and battery manufacturer) of China hired the task force, employing 3,000 engineers to build production lines at an existing plant in Shenzhen, using 90% of its self-made parts. He became the world’s largest mask maker in a month. Most health care companies had neither multiple engineers nor production capacity and tooling in a single unit. In India, Tata and Mahindra are now preparing to produce important materials like ventilators.
Health workers take up the asymmetric part of the infection. Safety of health workers is particularly important in India as it faces acute shortage of doctors and nurses. In China and Italy, the fight against coronovirus has killed large numbers of health workers. It is important to protect the health workers who live in the front line. It is essential that we ensure personal safety kits – gloves, coveralls, goggles, N-95 masks, shoe covers, face shields, triple-layer medical masks – and provide adequate food and comfort in hospitals. We are very appreciative that the Government of India has provided health insurance of Rs 50 lakhs to all health workers.
We have encountered five epidemics in the last 20 years (one epidemic every five years). If countries are to become truly strong for the epidemic, it is necessary that they adopt the principle of ‘passive aid associations’. The essence is that digital models of epidemics should be created and countries are put on a standstill with the best supply-chain experts from various industries and are requested to find effective synergies that they are not aware of To deal with such situations exist. Governments should identify companies (autos, electronics, apparel, among others) that have the ability to make certain categories of supplies needed on the scale and associate with specialized healthcare companies. A strong and lucid, timely intellectual property agreement can be prepared. A right of regulatory and standards agencies
*Amitabh Kant is the CEO of NITI Aayog and Kovthamraj VS is a young professional. The views expressed are his personal.